New test for finding germs in spinal fluid during brain infections
Part of Brain & nervous system, Infections clinical trials.
This study tests a new type of test called Delve Detect that looks for germs in spinal fluid from people suspected of having a brain or spinal cord infection. It helps doctors find the cause faster and more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your guardian must agree to join the study.
- You must have at least two symptoms of a brain or spine infection (like headache, fever, stiff neck, confusion, or new seizures).
- Your spinal fluid must show signs of infection (white blood cells), unless you have a weak immune system.
- The spinal fluid sample must come from your first spinal tap and be enough (at least half a milliliter).
- The sample must be stored correctly (not left out too long, not frozen for too long, and not thawed too many times).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on people in Denmark who may have an infection in the brain or the fluid around the brain and spinal cord. Researchers aim to collect and compare diagnostic results for different infection types (viral meningitis, bacterial meningitis, encephalitis, and others) to help confirm the cause and guide care.
This study looks at spinal fluid (cerebrospinal fluid, or CSF) to find markers that may signal a brain or spinal tumor or related abnormal growth. If you have a suspected tumor near the CSF spaces, these results may help doctors better classify what’s going on.
This study will look at leftover spinal fluid from people with brain or nerve conditions to find proteins that may help diagnose or track these diseases. If you are already scheduled for a spinal tap or brain surgery, your extra fluid could be used for this research.
This study looks at how infections or inflammation involving the brain and spinal cord work, using patient data and samples. It may help researchers better understand these illnesses and improve future care.
This trial tests a method to quickly identify the cause of meningitis or encephalitis by looking at your symptoms and spinal fluid results. It may help doctors choose the right treatment faster.
This trial studies whether certain inflammatory biomarkers in blood and spinal fluid can help diagnose autoimmune diseases affecting the brain and spinal cord. It may help people who are undergoing testing for white matter lesions.
Hear when a new Central Nervous System Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.